Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetic variation in anti-diabetic drug targets and risk of atrial fibrillation: a drug-target mendelian randomization study

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:21
  • Read more about Genetic variation in anti-diabetic drug targets and risk of atrial fibrillation: a drug-target mendelian randomization study

Exploring Contraindicated Medications and Corresponding Targeted Genes for Migraine Through Integrated Genetic Approaches

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:20
  • Read more about Exploring Contraindicated Medications and Corresponding Targeted Genes for Migraine Through Integrated Genetic Approaches

Causal effects of dietary antioxidants on epigenetic age: A two-sample Mendelian randomization study

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:18
  • Read more about Causal effects of dietary antioxidants on epigenetic age: A two-sample Mendelian randomization study

Genetic evidence of dietary patterns and diet-derived antioxidants on polyp development through gut microbiota modulation

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:15
  • Read more about Genetic evidence of dietary patterns and diet-derived antioxidants on polyp development through gut microbiota modulation

Phenome-wide Mendelian randomization analysis reveals new risk factors for 4 inflammatory skin diseases

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:14
  • Read more about Phenome-wide Mendelian randomization analysis reveals new risk factors for 4 inflammatory skin diseases

Follistatin levels and endocrine disorders: A two-sample Mendelian randomization study

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:13
  • Read more about Follistatin levels and endocrine disorders: A two-sample Mendelian randomization study

Identification of circulating inflammatory proteins as potential drug targets for sepsis through Mendelian randomization and colocalization analyses

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:12
  • Read more about Identification of circulating inflammatory proteins as potential drug targets for sepsis through Mendelian randomization and colocalization analyses

Identifying potential drug targets for cerebral amyloid angiopathy: A Mendelian randomization study based on the druggable genes

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:10
  • Read more about Identifying potential drug targets for cerebral amyloid angiopathy: A Mendelian randomization study based on the druggable genes

The mediating role of dietary habits in the causal relationships between frailty, depression, and gastroesophageal reflux disease

Submitted by Anna Hakala on Mon, 11/24/2025 - 09:08
  • Read more about The mediating role of dietary habits in the causal relationships between frailty, depression, and gastroesophageal reflux disease

Causal effect between systemic inflammatory cytokines and osteoporotic pathological fractures: A bidirectional Mendelian randomization study

Submitted by Anna Hakala on Mon, 11/24/2025 - 08:42
  • Read more about Causal effect between systemic inflammatory cytokines and osteoporotic pathological fractures: A bidirectional Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Current page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement